Moderna and Flagship Pioneering: Noubar Afeya...

Today’s callers: Daisy in the United Kingdom looks to grow her barefoot shoe brand across the pond in the United States. Then Rachel in Pennsylvania considers private labeling for her protein-packed sprinkles. And Andrew in California wonders whether he should seek investment for ...  Show more

When Maxine Clark left a top job in retail to start a make-your-own stuffed animal store, people thought she’d lost her mind. Investors doubted it. Friends questioned it. Retail experts couldn't understand how it would scale.But drawing on more than 20 years as a retail executive ...  Show more

Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” tha ...  Show more

The founders of German biotechnology company BioNTech were researching how to fight cancers using messenger RNA, "the unloved cousin of DNA", when covid-19 first appeared and they realised mRNA could be used to make a vaccine for the disease. Financial Times journalist Joe Miller ...  Show more

Es prinicpios de enero de 2020, y un misterioso virus nuevo está azotando la ciudad china de Wuhan.Al comienzo, el brote apenas llega a las noticias, pero cuando la amenaza llama la atención, los científicos se ponen en acción para hacer una vacuna. Pero el panorama es sombrío – ...  Show more

Today, we will be diving into Moderna. Founded in 2010, Moderna and its innovative RNA platform made headlines after developing one of the first COVID vaccines. We treated this Breakdown slightly different than our other episodes. I’m joined today by two guests. First, I am joine ...  Show more